Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

AChR Myasthenia Gravis Clinical Trials

2 recruiting trials for AChR Myasthenia Gravis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 1 / Phase 2NCT06106672

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-106.

Sponsor: COUR Pharmaceutical Development Company, Inc.Enrolling: 5417 locations
RECRUITINGPhase 4NCT06860633

Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod

This study plans to learn more about if the drug efgartigimod can be used in the hospital to treat exacerbations in participants with myasthenia gravis (MG). Efgartigimod has been...

Sponsor: University of Colorado, DenverEnrolling: 201 location